Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Healthcare
Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Quantum BioPharma Ltd
Bullboard Posts
User Avatar Image
(38)
•••
Comment by cloinveston Mar 11, 2019 4:17pm
47 Views
Post# 29469891

RE:RE:RE:RE:To produce 1000kg/harvest you need 4000-7000 plants

RE:RE:RE:RE:To produce 1000kg/harvest you need 4000-7000 plants
OllyOlly wrote: Pretty bad that 8 months ago, they had $50 million dollars cash and a deal to get another $55+ million from Auxly.. now they have $20 million dollars, no partner, nothing to show for it, and need "collateral".. LOL. And all this wasted time and effort and they don't even have anything to show for it. Literally nothing. Same amount of grow space they had 8 months and $30 million dollars ago.. pathetic.
guttock_cp wrote: They are not selling it but using it as collateral if they need financing for future expansion. Thats their final resort.


Spothoodman wrote: Totally agree! Only drawback they actually maybe thinking of Selling their location & leasing it back because they are not ( landlords) go figure! The only tangible asset they have & pumped only to " how can they even consider selling their location. They showld be selling product not assets.






I believe it was 37 million they started with not 50
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities